Identification of nodal metastases in melanoma using Sox-10

American Journal of Dermatopathology

Volumn 33, Issue 5, 2011, Pages 474-482

  Jennings, Charay ^a   Kim, Jinah ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

isolated tumor cells; melanoma; micrometastasis; S100; sentinel lymph node; Sox 10

Indexed keywords

MELAN A; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; TRANSCRIPTION FACTOR SOX10;

ADULT; AGED; ARTICLE; CELL ISOLATION; CHILD; CONTROLLED STUDY; DENDRITIC CELL; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MELANOCYTE; MELANOMA; MELANOPHAGE; MICROMETASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL; TUMOR DIAGNOSIS;

HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MELANOMA; RETROSPECTIVE STUDIES; S100 PROTEINS; SKIN NEOPLASMS; SOXE TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959823828     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182042893     Document Type: Article

References (27)

1. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update part I. J Am Acad Dermatol. 2010;62:723-734; quiz 735-736.
2. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update part II. J Am Acad Dermatol. 2010;62:737-748; quiz 749-750.
3. Liszkay G, Peley G, Sinkovics I, et al. Clinical significance of sentinel lymph node involvement in malignant melanoma. Pathol Oncol Res. 2003;9:184-187. (Pubitemid 37429499)
4. Rutkowski P, Nowecki ZI, Nasierowska-Guttmejer A, et al. Lymph node status and survival in cutaneous malignant melanoma-sentinel lymph node biopsy impact. Eur J Surg Oncol. 2003;29:611-618. (Pubitemid 37121764)
5. Keijzer R, Bril H, van der Loo EM, et al. Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma. Ned Tijdschr Geneeskd. 2004;148:884-888. (Pubitemid 38619118)
6. Satzger I, Volker B, Meier A, et al. Prognostic significance of isolated HMB45 or melan A positive cells in melanoma sentinel lymph nodes. Am J Surg Pathol. 2007;31:1175-1180. (Pubitemid 47207119)
7. Murray CA, Leong WL, McCready DR, et al. Histopathological patterns of melanoma metastases in sentinel lymph nodes. J Clin Pathol. 2004;57: 64-67. (Pubitemid 38091313)
8. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26: 4296-4303.
9. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255-260.
10. Spanknebel K, Coit DG, Bieligk SC, et al. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: Recommendations for standardizing pathologic analysis. Am J Surg Pathol. 2005;29:305-317. (Pubitemid 40321965)
11. Ohsie SJ, Sarantopoulos GP, Cochran AJ, et al. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35:433-444. (Pubitemid 351519417)
12. Nonaka D, Chiriboga L, Rubin BP. Sox10: A pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32:1291-1298.
13. Ramos-Herberth FI, Karamchandani J, Kim J, et al. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol. 2010;37:944-952.
14. Blochin E, Nonaka D. Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes. Histopathology. 2009;55:626-628.
15. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27: 6199-6206.
16. Karimipour DJ, Lowe L, Su L, et al. Standard immunostains for melanoma in sentinel lymph node specimens: Which ones are most useful? J Am Acad Dermatol. 2004;50:759-764. (Pubitemid 38580556)
17. Kucher C, Zhang PJ, Acs G, et al. Can melan-A replace S-100 and HMB-45 in the evaluation of sentinel lymph nodes from patients with malignant melanoma? Appl Immunohistochem Mol Morphol. 2006;14: 324-327. (Pubitemid 44319059)
18. Murali R, Thompson JF, Shaw HM, et al. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients. Am J Surg Pathol. 2008;32:1106-1107; author reply 1107-1108.
19. Scheri RP, Essner R, Turner RR, et al. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14:2861-2866. (Pubitemid 47460638)
20. Rimoldi D, Lemoine R, Kurt AM, et al. Detection of micrometastases in sentinel lymph nodes from melanoma patients: Direct comparison of multimarker molecular and immunopathological methods. Melanoma Res. 2003;13:511-520. (Pubitemid 37266954)
21. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: A clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197-1202. (Pubitemid 37040581)
22. Shidham VB, Qi DY, Acker S, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: Higher diagnostic accuracy with melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol. 2001;25:1039-1046. (Pubitemid 32685901)
23. Baisden BL, Askin FB, Lange JR, et al. HMB-45 immunohistochemical staining of sentinel lymph nodes: A specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol. 2000;24:1140-1146. (Pubitemid 30612836)
24. Mahmood MN, Lee MW, Linden MD, et al. Diagnostic value of HMB-45 and anti-Melan A staining of sentinel lymph nodes with isolated positive cells. Mod Pathol. 2002;15:1288-1293. (Pubitemid 35462996)
25. Miettinen M, Fernandez M, Franssila K, et al. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: Comparison with four other melanoma markers. Am J Surg Pathol. 2001;25:205-211. (Pubitemid 32167502)
26. O'Reilly FM, Brat DJ, McAlpine BE, et al. Microphthalmia transcription factor immunohistochemistry: A useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. J Am Acad Dermatol. 2001;45:414-419. (Pubitemid 32800499)
27. Granter SR, Weilbaecher KN, Quigley C, et al. Microphthalmia transcription factor: Not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol. 2001;23:185-189. (Pubitemid 32525406)